Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections

Anna Berggren; Irini Lazou Ahrén; Niklas Larsson; Gunilla Önning

首页> 外文期刊>European Journal of Nutrition >Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections

【24h】

Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections

机译：使用新型益生菌乳酸菌的随机，双盲和安慰剂对照研究可增强机体抵抗病毒感染的免疫力

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The aim of this study was to investigate whether consumption of Lactobacillus plantarum HEAL 9 (DSM 15312) and Lactobacillus paracasei 8700:2 (DSM 13434) could affect naturally acquired common cold infections in healthy subjects.

机译：这项研究的目的是调查食用植物乳杆菌HEAL 9（DSM 15312）和副干酪乳杆菌8700：2（DSM 13434）是否会影响健康受试者的自然获得性普通感冒感染。

著录项

来源
《European Journal of Nutrition》 |2011年第3期|p.203-210|共8页
作者
Anna Berggren; Irini Lazou Ahrén; Niklas Larsson; Gunilla Önning;
展开▼
作者单位

Probi AB, Ideon, Gamma 1, 223 70, Lund, Sweden;

Probi AB, Ideon, Gamma 1, 223 70, Lund, Sweden;

Probi AB, Ideon, Gamma 1, 223 70, Lund, Sweden;

Probi AB, Ideon, Gamma 1, 223 70, Lund, Sweden;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Probiotic; Immune defence; Common cold; Lactobacillus plantarum; Lactobacillus paracasei; DSM 15312; DSM 13434;

机译：益生菌;免疫防御;普通感冒;植物乳杆菌;副干酪乳杆菌;DSM 15312;DSM 13434;

相似文献

外文文献
中文文献
专利

1. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. [J] . Berggren A, Lazou Ahren I, Larsson N, European journal of nutrition . 2011,第3期

机译：使用新型益生菌乳酸菌的随机，双盲和安慰剂对照研究，可增强机体抵抗病毒感染的免疫防御能力。
2. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections [J] . European Dairy Magazine . 2010,第5期

机译：使用新型益生菌乳酸菌的随机，双盲和安慰剂对照研究可增强机体抵抗病毒感染的免疫力
3. Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. [J] . Rautava S., Salminen S., Isolauri E. The British Journal of Nutrition . 2009,第11期

机译：特殊的益生菌可降低婴儿期急性感染的风险-一项随机，双盲，安慰剂对照的研究。
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. A Phase 1B, Double-blind, Placebo-controlled, Parallel-group, Multi-dose Study of the Pharmacodynamics of NGM282 on Colonic Transit, Bile Acid Homeostasis and Fecal Fat in Subjects with Functional Constipation [D] . Oduyebo, Ibironke. 2018

机译：1B，双盲，安慰剂控制，并行组，NGM282对结肠转运，胆汁酸痛和患者功能性便秘的粪便脂肪的药物动力学的多剂量研究
6. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4 randomised placebo-controlled double-blind study [O] . Jiří Beran, Eva Šalapová, Marian Špajdel 2016

机译：肌苷Pranobex对于已确诊的急性呼吸道病毒感染的受试者是安全有效的：来自阶段4随机安慰剂对照双盲研究的分析和亚组分析
7. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study [O] . Jiří Beran, null null, Eva Šalapová, 2016

机译：肌苷Pranobex对于已确诊的急性呼吸道病毒感染的受试者是安全有效的：来自阶段4，随机，安慰剂对照，双盲研究的分析和亚组分析

Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections

摘要

著录项

相似文献

相关主题

期刊订阅